103 Results for "

DNA damage response

" in MedChemExpress (MCE) Product Catalog:
Products (103)

103 Results for "DNA damage response" in MCE Product Catalog:

17
17 Publications Verification
Cat. No.: HY-101566
CAS No.: 1876467-74-1
Purity:  99.99%
Synonyms: BAY 1895344
Target:  

ATM/ATR

Research Areas:  

Cancer

Elimusertib (BAY-1895344) is a potent, orally active and selective ATR inhibitor with an IC50 of 7 nM. Elimusertib has anti-tumor activity . Elimusertib can be used for the research of solid tumors and lymphomas .
loading...
    loading...
17
17 Publications Verification
Cat. No.: HY-101566A
Purity:  99.85%
Synonyms: BAY 1895344 hydrochloride
Target:  

ATM/ATR

Research Areas:  

Cancer

Elimusertib (BAY 1895344) hydrochloride is a potent, orally active and selective ATR inhibitor with an IC50 of 7 nM. Elimusertib hydrochloride has anti-tumor activity . Elimusertib hydrochloride can be used for the research of solid tumors and lymphomas .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-12484
CAS No.: 896705-16-1
Purity:  99.25%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

BMH-21 is a first-in-class DNA intercalator which inhibits RNA polymerase I (Pol I) transcription. BMH-21 possesses anticancer activity .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-109566
CAS No.: 2089288-03-7
Purity:  99.22%
Synonyms: AZD1390
Research Areas:  

Cancer

Elrelesertib (AZD1390) is an orally active, brain-penetrant ATM kinase inhibitor with IC50 values of 0.78 nM. Elrelesertib blocks ATM-dependent DNA damage response, inhibits ATM autophosphorylation and downstream Chk2, Rad50 phosphorylation, and accumulates at DNA breaks. Elrelesertib acts as a radiosensitizer, induces apoptosis, genomic instability, G2-M cell cycle arrest, ROS elevation, and mitochondrial membrane potential alteration. Elrelesertib has low efflux liability against P-gp and BCRP. Elrelesertib can be used for the research of central nervous system malignancies, glioblastoma multiforme, glioma, lung cancer brain metastases, and breast cancer .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-123834
CAS No.: 824983-91-7
Purity:  99.85%
Target:  

FLAP ATM/ATR

Research Areas:  

Cancer

FEN1-IN-1 (compound 1) is a small molecule flap endonuclease 1 (FEN1) inhibitor with antitumor activity. FEN1-IN-1 binds to the active site of FEN1 and partly achieves inhibition by the co-ordination of Mg 2+ ions. FEN1-IN-1 initiaties a DNA damage response and activates the ATM checkpoint signalling pathway, the phosphorylation of histone H2AX and the ubiquitination of FANCD2 in mammalian cells. FEN1-IN-1 is promising for research of cancers .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-B0077
CAS No.: 3543-75-7
Synonyms: SDX-105
Bendamustine hydrochloride (SDX-105), a purine analogue, is a DNA cross-linking agent. Bendamustine hydrochloride activats DNA-damage stress response and apoptosis. Bendamustine hydrochloride has potent alkylating, anticancer and antimetabolite properties .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-13567
CAS No.: 16506-27-7
Purity:  ≥98.0%
Synonyms: SDX-105 free base
Bendamustine (SDX-105 free base), a purine analogue, is a DNA cross-linking agent. Bendamustine activates DNA-damage stress response and apoptosis. Bendamustine has potent alkylating, anticancer and antimetabolite properties .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-114869
CAS No.: 129075-73-6
Purity:  99.68%
Target:  

PARP

Research Areas:  

Neurological Disease Cancer

DPQ is a selective PARP-1 inhibitor that blocks PARP-1-mediated DNA damage repair and NAD +/ATP consumption, thereby inhibiting excessive inflammatory responses. DPQ inhibits NF-κB pathway activation, reduces the expression of pro-inflammatory factors (such as TNF-α, IL-6) and oxidative stress. DPQ can be used in inflammation-related studies of acute lung injury, myocardial infarction, and neurodegenerative diseases .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-W424851
CAS No.: 84050-22-6
Synonyms: 6,7-Dimethoxy-2-(1-piperazinyl)-4-quinazolinamine hydrochloride
Target:  

PARP

Research Areas:  

Infection Inflammation/Immunology

DPQ hydrochloride is a blood-brain barrier permeable and selective PARP-1 inhibitor that blocks PARP-1-mediated DNA damage repair and NAD +/ATP consumption, thereby inhibiting excessive inflammatory responses. DPQ hydrochloride inhibits NF-κB pathway activation, reduces the expression of pro-inflammatory factors (such as TNF-α, IL-6) and oxidative stress. DPQ hydrochloride can be used in inflammation-related studies of acute lung injury, myocardial infarction, and neurodegenerative diseases .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-126020
CAS No.: 2290527-07-8
Purity:  99.90%
Target:  

DNA/RNA Synthesis RAD51

Research Areas:  

Cancer

Bractoppin is a potent and selective agent-like inhibitor of phosphopeptide recognition by the human BRCA1 tandem(t) BRCT domain (binding IC50: 74 nM). Bractoppin diminishes BRCA1 recruitment to DNA breaks, in turn suppressing damage-induced G2 arrest and assembly of the recombinase, RAD51. Bractoppin preferentially inhibits BRCA1 tBRCT-dependent steps in the DNA damage response .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-116217
CAS No.: 10356-76-0
Purity:  99.87%
Synonyms: FdCyd; NSC-48006
Target:  

DNA Methyltransferase

Research Areas:  

Cancer

5-Fluoro-2'-deoxycytidine (FdCyd), a fluoropyrimidine nucleoside analogue, is a DNA methyltransferase (DNMT) inhibitor. 5-Fluoro-2'-deoxycytidine is a tumor-selective proagent of thymidylate synthase inhibitor 5-fluoro-2′-dUMP. 5-Fluoro-2'-deoxycytidine can induce cell cycle arrest in tumor cells through the DNA damage response, and it has anti-tumor activity .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-112130
CAS No.: 2201066-53-5
Purity:  99.59%
Research Areas:  

Cancer

AGI-24512 is a potent methionine adenosyltransferase 2α (MAT2A) inhibitor, with an IC50 of 8 nM. AGI-24512 triggers DNA damage response. AGI-24512 can block proliferation of MTAP-deleted cancer cells in vitro. AGI-24512 can be used for researching anticancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-122198
CAS No.: 381168-77-0
Purity:  99.84%
Research Areas:  

Cancer

ML367 is a potent inhibitor of ATPase family AAA domain-containing protein 5 (ATAD5) stabilization, acts as a probe molecule that has low micromolar inhibitory activity. ML367 blocks DNA repair pathways, suppresses general DNA damage responses including RPA32-phosphorylation and CHK1-phosphorylation in response to UV irradiation .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13703A
CAS No.: 55661-38-6
Purity:  98.22%
Synonyms: ACNU
Nimustine hydrochloride (ACNU) is the hydrochloride salt form of Nimustine (HY-13703). Nimustine hydrochloride is an alkylating agent, which induces DNA double-strand breaks (DSBs) and inter-strand crosslinks (ICLs), thereby activating the DNA damage response (DDR) signaling pathway. Nimustine hydrochloride activates p38 MAPK/JNK signaling pathway, and exhibits antitumor activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-144981
CAS No.: 1226443-41-9
Purity:  98.10%
Target:  

CDK Molecular Glues

Research Areas:  

Cancer

HQ461 is a molecular glue that promotes CDK12-DDB1 interaction to trigger cyclin K degradation. HQ461-mediated degradation of cyclin K impairs CDK12 function, resulting in decreased CDK12 substrate phosphorylation, downregulation of DNA damage response genes, and cell death .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-137924
CAS No.: 6505-99-3
Purity:  98.91%
Research Areas:  

Cancer

JA2131 is a small molecular inhibitor of Poly(ADP-ribose) Glycohydrolase (PARG) (IC50=0.4 μM). JA2131 regulate DNA damage responses, causes replication fork stalling and cancer cell death .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-120084
CAS No.: 2052301-24-1
Purity:  99.20%
Target:  

Casein Kinase

Research Areas:  

Cancer

BTX161, a thalidomide analog, is an effective CKIα degrader. BTX161 mediates human AML cell CKIα degradation more effectively than lenalidomide and activates the DNA damage response (DDR) and p53, while stabilizing p53 antagonist MDM2.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N1461
CAS No.: 17238-05-0
Synonyms: (±)-Dihydrodaidzein
Dihydrodaidzein is a dietary phytoestrogen. Dihydrodaidzein possesses functions including antioxidation, inhibition of DNA oxidative damage, regulation of lipid metabolism and maintenance of intestinal flora stability. Dihydrodaidzein induces apoptosis, regulates immune responses, modulates tumor-related factors, activates the Bmp-2 signaling pathway, inhibits NF-κB and MAPK, and exhibits anti-inflammatory activity. Dihydrodaidzein can be used in research related to cancer, cardiovascular diseases, osteoporosis and inflammatory diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-153244
CAS No.: 2088715-91-5
Purity:  98.07%
Target:  

CDK

Research Areas:  

Cancer

MFH290 is an orally active, selective covalent CDK12/CDK13 inhibitor, with an IC50 of 25 nM against human CDK12 and 49 nM against human CDK13. MFH290 reduces the phosphorylation level of CTD-RNAPII-Ser2, downregulates genes related to DNA damage response (DDR), and inhibits transcription factors regulated by super-enhancers. MFH290 can be used in research related to various cancers including leukemia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-153190
CAS No.: 2740522-79-4
Purity:  99.25%
Research Areas:  

Cancer

W1131 is a potent STAT3 inhibitor, triggering ferroptosis. W1131 suppresses cancer progression in gastric cancer cell subcutaneous xenograft model, organoids model, and PDX model. W1131 effectively alleviates chemical resistance of cancer cells to 5-FU (HY-90006). W1131 regulates cell cycle, DNA damage response, and oxidative phosphorylation, including IL6-JAK-STAT3 pathway and ferroptosis pathway .
loading...
    loading...